Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119
The gastrointestinal tract is increasingly viewed as critical in controlling glucose metabolism, because of its role in secreting multiple glucoregulatory hormones, such as glucagon like peptide-1 (GLP-1). Here we investigate the molecular pathways behind the GLP-1- and insulin-secreting capabilitie...
Main Authors: | Ahmad Arifin, Syamsul, Paternoster, Silvano, Carlessi, Rodrigo, Casari, Ilaria, Ekberge, Jeppe Hvidtfeldt, Maffucci, Tania, Newsholme, Philip, Rosenkilde, Mette M., Falasca, Marco |
---|---|
Format: | Article |
Language: | English English English |
Published: |
Elsevier
2018
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/64800/ http://irep.iium.edu.my/64800/ http://irep.iium.edu.my/64800/ http://irep.iium.edu.my/64800/7/64800_Oleoyl-lysophosphatidylinositol%20enhances_SCOPUS.pdf http://irep.iium.edu.my/64800/13/64800_Oleoyl-lysophosphatidylinositol%20enhances.pdf http://irep.iium.edu.my/64800/19/64800_Oleoyl-lysophosphatidylinositol%20enhances%20_WoS.pdf |
Similar Items
-
Lysophosphatidylinositol signalling and metabolic diseases
by: Ahmad Arifin, Syamsul, et al.
Published: (2016) -
Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
by: Ruban, Emily L., et al.
Published: (2014) -
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, Riccardo, et al.
Published: (2018) -
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
by: Elnaem, Mohamed Hassan, et al.
Published: (2019) -
Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
by: Elnaem, Mohamed Hassan, et al.
Published: (2017)